https://stock.noler.com/us/stock/nexus-biopharma-inc https://stock.noler.com/us/stock/nexus-biopharma-inc/accounts-payable https://stock.noler.com/us/stock/nexus-biopharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/nexus-biopharma-inc/accounts-payable-related-parties https://stock.noler.com/us/stock/nexus-biopharma-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/nexus-biopharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/nexus-biopharma-inc/adjustment-for-amortization https://stock.noler.com/us/stock/nexus-biopharma-inc/advertising-expense https://stock.noler.com/us/stock/nexus-biopharma-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/nexus-biopharma-inc/asset-impairment-charges https://stock.noler.com/us/stock/nexus-biopharma-inc/cash https://stock.noler.com/us/stock/nexus-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/nexus-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/nexus-biopharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/nexus-biopharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/nexus-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nexus-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/nexus-biopharma-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/nexus-biopharma-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/nexus-biopharma-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/nexus-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/nexus-biopharma-inc/current-assets https://stock.noler.com/us/stock/nexus-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/nexus-biopharma-inc/debt-face-amount https://stock.noler.com/us/stock/nexus-biopharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/nexus-biopharma-inc/debt-unamortized-discount https://stock.noler.com/us/stock/nexus-biopharma-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/nexus-biopharma-inc/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/nexus-biopharma-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/nexus-biopharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/nexus-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nexus-biopharma-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/nexus-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nexus-biopharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/nexus-biopharma-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/nexus-biopharma-inc/derivative-liabilities https://stock.noler.com/us/stock/nexus-biopharma-inc/derivative-liabilities-current https://stock.noler.com/us/stock/nexus-biopharma-inc/derivative-loss-on-derivative https://stock.noler.com/us/stock/nexus-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/nexus-biopharma-inc/due-to-officers-or-stockholders-current-and-noncurrent https://stock.noler.com/us/stock/nexus-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nexus-biopharma-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/nexus-biopharma-inc/exploration-expense-mining https://stock.noler.com/us/stock/nexus-biopharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/nexus-biopharma-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/nexus-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/nexus-biopharma-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-one-year https://stock.noler.com/us/stock/nexus-biopharma-inc/future-minimum-sublease-rentals-sale-leaseback-transactions-within-two-years https://stock.noler.com/us/stock/nexus-biopharma-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/nexus-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-leasing-receivables https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/nexus-biopharma-inc/increase-decrease-in-prepaid-rent https://stock.noler.com/us/stock/nexus-biopharma-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/nexus-biopharma-inc/interest-expense-related-party https://stock.noler.com/us/stock/nexus-biopharma-inc/interest-income-expense-net https://stock.noler.com/us/stock/nexus-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/nexus-biopharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/nexus-biopharma-inc/lease-incentive-receivable-current https://stock.noler.com/us/stock/nexus-biopharma-inc/liabilities-noncurrent https://stock.noler.com/us/stock/nexus-biopharma-inc/license-costs https://stock.noler.com/us/stock/nexus-biopharma-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/nexus-biopharma-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/nexus-biopharma-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/nexus-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/nexus-biopharma-inc/net-income https://stock.noler.com/us/stock/nexus-biopharma-inc/new-shares-sold https://stock.noler.com/us/stock/nexus-biopharma-inc/noncash-contribution-expense https://stock.noler.com/us/stock/nexus-biopharma-inc/notes-and-loans-payable-current https://stock.noler.com/us/stock/nexus-biopharma-inc/notes-payable-current https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/nexus-biopharma-inc/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/nexus-biopharma-inc/other-income https://stock.noler.com/us/stock/nexus-biopharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/nexus-biopharma-inc/payments-to-acquire-furniture-and-fixtures https://stock.noler.com/us/stock/nexus-biopharma-inc/payments-to-acquire-royalty-interests-in-mining-properties https://stock.noler.com/us/stock/nexus-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/nexus-biopharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nexus-biopharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nexus-biopharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/nexus-biopharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/nexus-biopharma-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/nexus-biopharma-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/nexus-biopharma-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/nexus-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/nexus-biopharma-inc/profit-loss https://stock.noler.com/us/stock/nexus-biopharma-inc/property-plant-equipment https://stock.noler.com/us/stock/nexus-biopharma-inc/public-float https://stock.noler.com/us/stock/nexus-biopharma-inc/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/nexus-biopharma-inc/research-and-development https://stock.noler.com/us/stock/nexus-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/nexus-biopharma-inc/revenue https://stock.noler.com/us/stock/nexus-biopharma-inc/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/nexus-biopharma-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/nexus-biopharma-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/nexus-biopharma-inc/share-price https://stock.noler.com/us/stock/nexus-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/nexus-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/nexus-biopharma-inc/shares-issued https://stock.noler.com/us/stock/nexus-biopharma-inc/shares-issued-2 https://stock.noler.com/us/stock/nexus-biopharma-inc/shares-issued-value-other https://stock.noler.com/us/stock/nexus-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/nexus-biopharma-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/nexus-biopharma-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/nexus-biopharma-inc/total-assets https://stock.noler.com/us/stock/nexus-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/nexus-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/nexus-biopharma-inc/unrealized-gain-on-securities https://stock.noler.com/us/stock/nexus-biopharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/nexus-biopharma-inc/valuation-allowances-and-reserves-change https://stock.noler.com/us/stock/nexus-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/nexus-biopharma-inc/weighted-average-number-of-shares-outstanding-basic-and-diluted